Catalysts

WHITE PAPERS AND CASE STUDIES

• RO Membrane Protection For A Desalination Plant In Mejillones, Chile

  Read about a seawater desalination plant that presented with several performance issues and chose the HOD UV system to control biofouling on the RO membranes.

• Streamlined Facility Design: A Success Story

  Examine how one medium-sized US company's need for a new aseptic compounding and fill-finish facility was addressed with a tailored solution within a challenging time-frame.

• Explore A High-Performing Basal Medium And Feed Pairing

  A customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.

• GxP Inventory Delivers Real-Time Visibility, Operational Efficiency

  Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.

• Optimizing Early-Stage Oncology

  A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.

• Relieving The Strain Of Publishing During Regulatory Registration

  Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.

• Aquatic Invasive Species Control At Hoover Dam

  In this case study, learn why Hoover Dam installed Atlantium's HOD UV treatment system to protect its cooling water systems from Quagga mussels.

• Keeping The Lights On With Wolfspeed SiC

  Introducing the “M” inverter, a modular, silicon carbide-based solution that optimizes utility-scale energy storage with higher efficiency, reliability, and scalability.

• Automated Trial Monitoring Workflows Make A Lean Team More Efficient

  A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.

• Navigate The Complexities Of CGTs With Regulatory And CMC Expertise

  Explore how strategic regulatory and CMC expertise helped guide a biopharmaceutical company’s regulatory and development strategy for a cell and gene therapy product.

• Bringing A Device From Concept To Market

  Within three years, see how this company was able to achieve FDA approval and CE Marking, facilitating its entry into the U.S. and EU markets.

• Rescuing A Global Program For NDA Success

  Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.